Medication info

Samsung Bi tablet 10/20 milligrams

Prescription medicationTabletOralExpired
Ingredient · strength
Ezetimibe›10mg / 1 tabletSimvastatin›20mg / 1 tablet
Manufacturer / importer
Samsung Pharmaceuticals Co., Ltd.
Appearance
White to off-white, double convex rectangular tablet
Packaging
30 tablets (10 tablets/PTP X 3)
Approval status
Expired

MFDS item code 201900195 · Approved 2019.01.16

This product's status changed to Expired on 2024.01.16. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Improvement of mixed hyperlipidemia and hypercholesterolemia (primary and homozygous familial)
Who takes it
Adults
Adult dose
Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. Administer this medicine once daily in the evening, without regard to meals. Patients with primary hypercholesterolemia The dose range is 10/10 mg to 10/40 mg once daily. The usual recommended starting dose is 10/20 mg once daily. Patients who require less LDL cholesterol reduction may start at 10/10 mg once daily. After starting treatment or adjusting the dose, adjust the dose after checking blood lipid levels at intervals of 4 weeks or longer. Because of the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this medicine should be used only in patients who have taken 10/80 mg of this medicine for 12 months or longer without evidence of muscle toxicity (see section 1, Warnings, under Precautions for Use). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40 mg once daily in the evening. This medicine is used as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not useful. Administration to patients with hepatic impairment No dose adjustment is required in patients with mild hepatic impairment; however, use of this medicine is not recommended in patients with moderate or severe hepatic impairment (see section 4, General Precautions, subsection on patients with abnormal liver function, under Precautions for Use). Administration to patients with renal impairment and chronic kidney disease No dose adjustment is required in patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). For patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡, administer 10/20 mg of this medicine once daily in the evening. Use caution and closely monitor these patients when administering higher doses of this medicine (see section 4, General Precautions, under Precautions for Use). Administration to older adults No dose adjustment is required in older adults. Concomitant administration with other medicines (See section 5, Interactions, under Precautions for Use.) Administer this medicine at least 2 hours before or 4 hours after administration of a bile acid sequestrant. Patients receiving this medicine concomitantly with verapamil, diltiazem, or dronedarone should not exceed 10/10 mg/day of this medicine. Patients receiving this medicine concomitantly with amiodarone, amlodipine, or ranolazine should not exceed 10/20 mg/day of this medicine.

Ingredients

Manufacturer
Samsung Pharmaceuticals Co., Ltd.

Efficacy & effects

Improvement of mixed hyperlipidemia and hypercholesterolemia (primary and homozygous familial)

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed hyperlipidemia
  • homozygous familial hypercholesterolemia
  • atherosclerotic vascular diseases due to hypercholesterolemia
  • dyslipidemia
View approved original text

This drug helps reduce elevated total cholesterol, LDL cholesterol, ApoB protein, and triglycerides in patients with primary hypercholesterolemia and mixed hyperlipidemia, while increasing HDL cholesterol. It is especially used as an adjunct or alternative to other lipid-lowering treatments in patients with homozygous familial hypercholesterolemia. It is important to identify and treat secondary causes considering other health conditions or medications taken. Blood lipid levels should be regularly monitored to evaluate the therapeutic effect. This drug is effectively used to reduce the risk of hypercholesterolemia and its associated atherosclerotic vascular diseases.

How to take

Adult dose

Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. Administer this medicine once daily in the evening, without regard to meals. Patients with primary hypercholesterolemia The dose range is 10/10 mg to 10/40 mg once daily. The usual recommended starting dose is 10/20 mg once daily. Patients who require less LDL cholesterol reduction may start at 10/10 mg once daily. After starting treatment or adjusting the dose, adjust the dose after checking blood lipid levels at intervals of 4 weeks or longer. Because of the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this medicine should be used only in patients who have taken 10/80 mg of this medicine for 12 months or longer without evidence of muscle toxicity (see section 1, Warnings, under Precautions for Use). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40 mg once daily in the evening. This medicine is used as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not useful. Administration to patients with hepatic impairment No dose adjustment is required in patients with mild hepatic impairment; however, use of this medicine is not recommended in patients with moderate or severe hepatic impairment (see section 4, General Precautions, subsection on patients with abnormal liver function, under Precautions for Use). Administration to patients with renal impairment and chronic kidney disease No dose adjustment is required in patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). For patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡, administer 10/20 mg of this medicine once daily in the evening. Use caution and closely monitor these patients when administering higher doses of this medicine (see section 4, General Precautions, under Precautions for Use). Administration to older adults No dose adjustment is required in older adults. Concomitant administration with other medicines (See section 5, Interactions, under Precautions for Use.) Administer this medicine at least 2 hours before or 4 hours after administration of a bile acid sequestrant. Patients receiving this medicine concomitantly with verapamil, diltiazem, or dronedarone should not exceed 10/10 mg/day of this medicine. Patients receiving this medicine concomitantly with amiodarone, amlodipine, or ranolazine should not exceed 10/20 mg/day of this medicine.

Precautions

This drug can cause serious muscle-related side effects, such as myopathy and rhabdomyolysis. If you experience muscle pain or weakness, consult a doctor immediately. This drug is not to be administered to patients with impaired liver function or active liver disease. Pregnant or breastfeeding women should not take this medication. The risk of side effects may be increased when taken with certain medications, so it is crucial to inform your doctor if you are taking other drugs. In particular, co-administering with medications that inhibit the metabolism of this drug in the liver may increase the risk of muscle damage. Regular liver function and muscle status checks are important while taking this drug. Caution is advised when using this drug in children or the elderly, and it should be taken under a doctor's guidance if necessary. As there are no specific antidotes for overdose, it is important to adhere to the prescribed dosage. Notify medical personnel immediately if you experience unexplained muscle pain or weakness during treatment with this drug.

Side effects

  • myopathy
  • rhabdomyolysis
  • elevated creatine kinase
  • headache
  • diarrhea
  • influenza
  • upper respiratory tract infection
  • myalgia
  • limb pain
  • fatigue
Show 71 more
  • abdominal pain
  • viral infection
  • pharyngitis
  • sinusitis
  • arthralgia
  • low back pain
  • cough
  • weakness
  • cataract
  • constipation
  • dyspepsia
  • flatulence
  • nausea
  • eczema
  • pruritus
  • rash
  • muscle cramp
  • immune-mediated necrotizing myopathy
  • taste disturbance
  • ocular motility disorder
  • facial muscle weakness
  • tremor
  • dizziness
  • sensory disturbance
  • peripheral neuropathy
  • peripheral nerve palsy
  • mental disorder
  • anxiety
  • sleep disorder
  • depression
  • interstitial lung disease
  • angioedema
  • rash
  • pancreatitis
  • nausea
  • cholelithiasis
  • cholecystitis
  • eczema
  • pruritus
  • rash
  • alopecia
  • various skin changes
  • lichenoid drug eruption
  • gynecomastia
  • decreased libido
  • sexual dysfunction
  • ocular muscle paralysis
  • anemia
  • elevated aminotransferases
  • elevated ALP
  • elevated ɤ-GT
  • elevated bilirubin level
  • thyroid dysfunction
  • elevated serum creatine kinase
  • abnormal liver function test
  • increased HbA1c
  • increased fasting blood glucose levels
  • edema
  • thirst
  • facial swelling
  • syncope
  • insomnia
  • gastritis
  • atrophic gastritis
  • dyspepsia
  • mucous stools
  • irritable bowel syndrome
  • sore throat
  • nocturia
  • hematuria
  • weight loss

Not everyone experiences these, and they can vary from person to person.

Storage

This drug should be stored in a tightly closed container, protected from air and moisture, and kept at room temperature between 1°C and 30°C. This helps to maintain the drug's effectiveness for a long period.

Appearance and packaging

Appearance

White to off-white, double convex rectangular tablet

Package unit

30 tablets (10 tablets/PTP X 3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.